Atlas Trials

Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT07695896 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07695896
Sponsor
Yanyan Liu
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Start date
2026-07-01
Primary completion
2028-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.